Related Experiment Video
Updated: Mar 24, 2026
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Anticancer Effects of Sinulariolide-Conjugated Hyaluronan Nanoparticles on Lung Adenocarcinoma Cells
Kuan Yin Hsiao1, Yi-Jhen Wu2, Zi Nong Liu3
1Department of Biomedical Engineering, College of Medicine, I-Shou University, Kaohsiung City 82445, Taiwan. kireihsiao@pie.com.tw.
Abstract:
Lung cancer is one of the most clinically challenging malignant diseases worldwide. Sinulariolide (SNL), extracted from the farmed coral species Sinularia flexibilis, has been used for suppressing malignant cells. For developing anticancer therapeutic agents, we aimed to find an alternative for non-small cell lung cancer treatment by using SNL as the target drug. We investigated the SNL bioactivity on A549 lung cancer cells by conjugating SNL with hyaluronan nanoparticles to form HA/SNL aggregates by using a high-voltage electrostatic field system. SNL was toxic on A549 cells with an IC50 of 75 µg/mL. The anticancer effects of HA/SNL aggregates were assessed through cell viability assay, apoptosis assays, cell cycle analyses, and western blotting. The size of HA/SNL aggregates was approximately 33-77 nm in diameter with a thin continuous layer after aggregating numerous HA nanoparticles. Flow cytometric analysis revealed that the HA/SNL aggregate-induced apoptosis was more effective at a lower SNL dose of 25 µg/mL than pure SNL. Western blotting indicated that caspases-3, -8, and -9 and Bcl-xL and Bax played crucial roles in the apoptotic signal transduction pathway. In summary, HA/SNL aggregates exerted stronger anticancer effects on A549 cells than did pure SNL via mitochondria-related pathways.
Insights
Sinulariolide (SNL) from coral, when conjugated with hyaluronan nanoparticles (HA/SNL), shows enhanced anticancer effects against non-small cell lung cancer cells. This novel HA/SNL aggregate formulation effectively induces apoptosis via mitochondrial pathways.
Area of Science:
- Biochemistry
- Nanotechnology
- Oncology
Background:
- Lung cancer remains a significant global health challenge.
- Sinulariolide (SNL), a compound from coral, exhibits potential anticancer properties.
- Developing novel therapeutic agents for non-small cell lung cancer (NSCLC) is critical.
Purpose of the Study:
- To investigate the anticancer efficacy of SNL conjugated with hyaluronan nanoparticles (HA/SNL) against A549 lung cancer cells.
- To explore the potential of HA/SNL aggregates as an alternative NSCLC treatment.
- To elucidate the mechanisms underlying the anticancer effects of HA/SNL.
Main Methods:
- Conjugation of SNL with hyaluronan nanoparticles using a high-voltage electrostatic field system to form HA/SNL aggregates.
- Assessment of SNL and HA/SNL cytotoxicity on A549 cells using cell viability assays (IC50 determination).
- Evaluation of anticancer effects via apoptosis assays, cell cycle analysis, and Western blotting to analyze key proteins in apoptotic pathways.
Main Results:
- SNL demonstrated toxicity against A549 cells with an IC50 of 75 µg/mL.
- HA/SNL aggregates, approximately 33-77 nm in size, showed enhanced apoptosis induction at a lower SNL concentration (25 µg/mL) compared to pure SNL.
- Western blotting confirmed the involvement of caspases-3, -8, -9, Bcl-xL, and Bax in the HA/SNL-induced apoptotic pathway.
Conclusions:
- HA/SNL aggregates exhibit superior anticancer effects on A549 lung cancer cells compared to pure SNL.
- The enhanced efficacy of HA/SNL aggregates is mediated through mitochondria-related apoptotic pathways.
- This study highlights the potential of nanoparticle-drug conjugates for improved NSCLC therapy.
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...